Macarius Donneyong

photo of Marcarius

Macarius Donneyong, PhD, MPH

Assistant Professor
Outcomes and Translational Sciences
404 Riffe Building
donneyong.1@osu.edu
(614) 292-0075

Professional Interests

Dr. Macarius Donneyong is an Assistant Professor with joint faculty appointments in the Colleges of Pharmacy and Public Health at The Ohio State University. He teaches courses on drug literature evaluation in the PharmD program and a graduate course on healthcare data analytics through the College of Public Health.

Research Interests

Dr. Donneyong’s research goal is to help improve the health of racial/ethnic minorities by generating information to improve adherence, safety and effectiveness of prescribed medication. His major research interest in this area include:

  • The direct and indirect role of social determinants of health on medication utilization, adherence and effectiveness.
  • The effect of patient-provider relationships on medication treatment outcomes.
  • How to prevent harmful effects of drug-drug interactions: polypharmacy increases exposure to drug-drug interaction and is more prevalent among racial/ethnic minorities because of higher prevalence of multiple chronic conditions.

Learn more about Dr. Donneyong's research interests.

Courses

The Ohio State University, College of Public Health
2018 – Present: PUBHHMP 6625; Leveraging Healthcare Data for Practice and Policy Change, Principal instructor

The Ohio State University, College of Pharmacy
2017 – Present: PHR 6303; Concepts in Patient Care, Co-instructor

Education

  • 2013, PhD, University of Louisville
  • 2009, MPH, Missouri State University
  • 2005, BSc, University of Ghana

Journal Articles

  • Donneyong MM, Chang T-J, Jackson JW, et al. Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment. Int. J. Environ. Res. Public Health 2020, 17, 6684; doi:10.3390/ijerph17186684. Accepted September 14, 2020.
  • Donneyong MM, Chang T, Roth AR, Guilds M, Ankrah D, Najafzadeh M, Xu WY, Chlebowski RT, Margolis K, Manson JE. The Women’s Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groups. Menopause. February 2020.
  • Donneyong MM, Kulik A, Gagne JJ. Patterns of Intravenous Corticosteroid Utilization in Patients Undergoing Coronary Artery Bypass Grafting Surgery in the US. Journal of Cardiovascular Pharmacology and Therapeutics. October 2017.
  • Donneyong MM, Reynolds CF, Mischoulon, D, et al.. A protocol for studying racial/ethnic disparities in depression care utilizing joint information from participant surveys and administrative claims databases: An observational cohort study. BMJ Open. January 2020.
  • Donneyong MM, Bykov K, Bosco-Levy P, Dong YH, Levin R, Gagne JJ. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study. British Medical Journal (BMJ). September 2016.
  • Maribel Salas, Luciane C Lopes, Brian Godman, Ilse Truter, Abraham G Hartzema, Bjorn Wettermark, Joseph Fadare, Johanita R Burger, Kwame Appenteng, Macarius Donneyong, Ariel Arias, Daniel Ankrah, Olayinka O Ogunleye, Martha Lubbe, Laura Horne, Jorgelina Bernet, Diana L Gómez‐Galicia, Miriam del Carmen Garcia Estrada, Margaret N Oluka, Amos Massele, Luis Alesso, Raquel Herrera Comoglio, Elisangela da Costa Lima, Carmen Vilaseca, Ulf Bergman. Challenges facing drug utilization research in the Latin American region. Pharmacoepidemiology and Drug Safety. May 2020.
  • Vyas CM, Donneyong MM, Mischoulon D, et. al. Associations between race and ethnicity and late-life depression severity, symptom burden and care. JAMA Open Network. March 2020.
  • Xu WY, Dowd BE, Donneyong MM, Li Y, Retchin SM. Cost-sharing payments for out-of-network care in commercially insured adults. Am J Manag Care. 2019 Dec;25(12):598-604.
  • Ankrah D, Hallas, J, Odei J, Asenso-Boadi F, Dsane-Selby L, Donneyong MM. A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research. Basic & Clinical Pharmacology & Toxicology. November 2018.
  • MS Sinha, CC Freifeld, JS Brownstein, MM Donneyong, P Rausch, et al. Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis. JMIR Public Health and Surveillance. January 2018.
  • Franklin JM, Donneyong M, Desai R, Markson L, Girman C, McKay C, Patel MD, Mavros P, Schneeweiss S. Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts: Evaluating multiple healthcare hierarchies. Journal of Comparative Effectiveness Research. September, 2017; in press.
  • Stevenson MD, Dayan PS, Dudley NC, Bajaj L, Macias CG, Bachur RG, Sinclair K, Bennett J, Mittal MK, Donneyong MM, Kharbanda AB. Time From Emergency Department Evaluation to Operation and Appendiceal Perforation. Pediatrics. May 2017.
  • Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications. Pharmacoepidemiol Drug Saf. April 2017.
  • Dong YH, Bykov K, Choudhry NK, Donneyong MM, et al. Clinical outcomes of concomitant use of warfarin and selective serotonin reuptake inhibitors: a multi-database observational cohort study. Journal of Clinical Psychopharmacology. December 2016.
  • K Bykov, S Schneeweiss, MM Donneyong, et al. Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors. Am J Cardiol. November 2016.
  • Luo J, Seeger JD, Donneyong MM, Gagne JJ, Avorn J, Kesselheim AS. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending. JAMA Intern Med. September 2016.
  • Donneyong MM, Taylor KC, Kerber RA, Hornung CA, Scragg R. Is outdoor recreational activity an independent predictor of cardiovascular disease mortality - NHANES III? Nutr Metab Cardiovasc Dis. 2016 Aug;26 (8):735-42.
  • A genome-wide association study meta-analysis of clinical fracture in 10,012 African American women. Taylor KC, Evans DS, Edwards DRV, Edwards TL, Sofer T, Li G, Liu Y, Franceschini N, Jackson RD, Giri A, Donneyong M, Psaty B, Rotter JI, LaCroix AZ, Jordan JM, Robbins JA, Lewis B, Stefanick ML, Liu Y, Garcia M, Harris T, Cauley JA, North KE. Bone Rep. August 2016.
  • Esposito DB, Lanes S, Donneyong MM, Holick CN, Lasky JA, Lederer D, Nathan SD, O'Quinn S, Parker J, Tran TN. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation. Am J Respir Crit Care Med. November 2015.
  • Huang J*, Donneyong MM*, Trivedi J, Barnard A, Chaney J, Dotson A, Raymer S, Cheng A, Liu H, Slaughter MS. Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations. Ann Thorac Surg. June 2015.
  • Donneyong MM, Hornung CA, Taylor KC, Baumgartner RN, Myers JA, Eaton CB, Gorodeski EZ, Klein L, Martin LW, Shikany JM, Song Y, Li W, Manson JE. Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative. Circ Heart Fail. January 2015.
  • Donneyong MM, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter MS. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality. ASAIO J. May 2014.
  • Bhatia N, Abushora MY, Donneyong MM, Stoddard MF. Determination of the optimum number of cardiac cycles to differentiate intra-pulmonary shunt and patent foramen ovale by saline contrast two- and three-dimensional echocardiography. Echocardiography. March 2014.